# Study to Assess Long-Term Safety/Tolerability of Enobosarm (GTx 024) in Stress Urinary Incontinence

> **NCT03566290** · PHASE2 · WITHDRAWN · sponsor: **GTx**

## Conditions studied

- Stress Urinary Incontinence

## Interventions

- **DRUG:** GTx-024

## Key facts

- **NCT ID:** NCT03566290
- **Lead sponsor:** GTx
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-06-28
- **Primary completion:** 2018-09-21
- **Final completion:** 2018-09-21
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Development of investigational product was halted.
- **Last updated:** 2024-03-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03566290

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03566290, "Study to Assess Long-Term Safety/Tolerability of Enobosarm (GTx 024) in Stress Urinary Incontinence". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03566290. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*